Matinas BioPharma Holdings, Inc.·4

Sep 11, 9:00 AM ET

Rongen Roelof 4

4 · Matinas BioPharma Holdings, Inc. · Filed Sep 11, 2017

Insider Transaction Report

Form 4
Period: 2017-09-08
Rongen Roelof
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2017-09-08$1.36/sh+5,000$6,8003,539,416 total

Documents

1 file
  • 4
    rongen_form4sep82017.xmlPrimary

    OWNERSHIP DOCUMENT